Related Experiment Video

Updated: May 19, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis?

Amanullah Abbasi1, Abdul Rabb Bhutto, Nazish Butt

  • 1Medical Unit-III, Civil Hospital and Dow University of Health Sciences, Karachi. draman_ullah2000@yahoo.com

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|August 8, 2012
PubMed

Insights

Low serum cholesterol is common in decompensated chronic liver disease and correlates with disease severity. This finding can improve the assessment of chronic liver disease prognosis using the Child-Pugh classification.

Area of Science:

  • Hepatology
  • Biochemistry
  • Clinical Medicine

Background:

  • Decompensated chronic liver disease (CLD) presents complex metabolic alterations.
  • Serum lipid profiles, particularly cholesterol, are altered in various liver conditions.
  • The Child-Pugh classification is a standard tool for assessing liver disease severity.

Purpose of the Study:

  • To investigate the association between serum cholesterol levels and the Child-Pugh class in patients with viral hepatitis-induced decompensated CLD.
  • To evaluate if serum cholesterol can serve as a prognostic marker in CLD.

Main Methods:

  • A cross-sectional study involving 114 patients with viral hepatitis-induced cirrhosis.
  • Patients were categorized into four groups based on serum total cholesterol levels.
  • Hepatic dysfunction was assessed using the Child-Pugh scoring system.
  • Statistical analysis included Chi-square and Spearman's correlation tests.

Main Results:

  • A significant inverse association was found between serum total cholesterol and triglycerides with Child-Pugh class (p=0.0001 and p=0.004).
  • Higher Child-Pugh scores (indicating more severe liver dysfunction) correlated with lower serum cholesterol and triglyceride levels.
  • Males exhibited significantly lower cholesterol levels than females (p=0.006).

Conclusions:

  • Hypocholesterolemia is prevalent in decompensated CLD and significantly associated with Child-Pugh class.
  • Serum cholesterol levels may enhance the reliability of the Child-Pugh classification for assessing CLD severity and prognosis.
  • These findings suggest cholesterol levels as a potential biomarker in managing chronic liver disease.
Abstract

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...